The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
The risk of herpes zoster in patients with rheumatoid arthritis in the United States and the United Kingdom
Abstract
Objective: To determine whether the incidence of herpes zoster is elevated in patients with rheumatoid arthritis (RA) and whether herpes zoster is associated with use of disease‐modifying antirheumatic drugs (DMARDs) in patients with RA. Methods: Two retrospective cohort studies were conducted using data from a US integrated managed care database (PharMetrics claims database) from 1998–2002 and the UK General Practice Research Database (GPRD) between 1990–2001. Rates of herpes zoster among patients with RA and randomly sampled non‐RA patients were compared. A nested case–control analysis was performed within each RA cohort to examine the effect of current treatment on herpes zoster risk. Results: A total of 122,272 patients with RA from the PharMetrics database and 38,621 from the GPRD were included. The adjusted hazard ratios of herpes zoster for patients with RA compared with non‐RA patients were 1.91 (95% confidence interval [95% CI] 1.80–2.03) in the PharMetrics database and 1.65 (95% CI 1.57–1.75) in the GPRD. In the PharMetrics database, current use of biologic DMARDs alone was associated with herpes zoster (odds ratio [OR] 1.54, 95% CI 1.04–2.29), as was current use of traditional DMARDs alone (OR 1.37, 95% CI 1.18–1.59). In the GPRD, current use of traditional DMARDs was associated with herpes zoster (OR 1.27, 95% CI 1.10–1.48). In both data sources, use of oral corticosteroids was associated with herpes zoster regardless of concomitant therapies. Conclusion: Data from 2 large databases suggested that patients with RA are at increased risk of herpes zoster. Among patients with RA, DMARDs and/or use of oral corticosteroids appeared to be associated with herpes zoster.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bongartz, T., Sutton, A. J., Sweeting, M. J., Buchan, I., Matteson, E. L., & Montori, V. (2006) · JAMA · doi:10.1001/jama.295.19.2275 · Cited by 2,468
The Nature of Herpes Zoster: A Long-Term Study and a New Hypothesis
Hope-Simpson, R. E. (1965) · Proceedings of the Royal Society of Medicine · doi:10.1177/003591576505800106 · Cited by 1,386
The mortality of rheumatoid arthritis
Wolfe, F., Mitchell, D. M., Sibley, J. T., Fries, J. F., Bloch, D. A., Williams, C. A., Spitz, P. W., Haga, M., Kleinheksel, S. M., & Cathey, M. A. (1994) · Arthritis & Rheumatism · doi:10.1002/art.1780370408 · Cited by 1,310
Doran, M. F., Crowson, C. S., Pond, G. R., O'Fallon, W. M., & Gabriel, S. E. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10524 · Cited by 1,214
Neurologic Complications of the Reactivation of Varicella–Zoster Virus
Gilden, D. H., Kleinschmidt-DeMasters, B. K., LaGuardia, J. J., Mahalingam, R., & Cohrs, R. J. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003023420906 · Cited by 853
Jick, H., Jick, S. S., & Derby, L. E. (1991) · BMJ · doi:10.1136/bmj.302.6779.766 · Cited by 839
Risk of Infectious Complications in Patients Taking Glucocorticosteroids
Stuck, A. E., Minder, C. E., & Frey, F. J. (1989) · Clinical Infectious Diseases · doi:10.1093/clinids/11.6.954 · Cited by 836
Gnann, J. W., & Whitley, R. J. (2002) · New England Journal of Medicine · doi:10.1056/nejmcp013211 · Cited by 781
Dixon, W. G., Watson, K., Lunt, M., Hyrich, K. L., Silman, A. J., & Symmons, D. P. M. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21978 · Cited by 751
Infections in patients with rheumatoid arthritis treated with biologic agents
Listing, J., Strangfeld, A., Kary, S., Rau, R., von Hinueber, U., Stoyanova‐Scholz, M., Gromnica‐Ihle, E., Antoni, C., Herzer, P., Kekow, J., et al. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21386 · Cited by 681
Validity of the General Practice Research Database
Jick, S. S., Kaye, J. A., Vasilakis‐Scaramozza, C., Rodríguez, L. A. G., Ruigómez, A., Meier, C. R., Schlienger, R. G., Black, C., & Jick, H. (2003) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.23.5.686.32205 · Cited by 584
What does epidemiology tell us about risk factors for herpes zoster?
Thomas, S. L., & Hall, A. J. (2004) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(03)00857-0 · Cited by 561
Predictors of infection in rheumatoid arthritis
Doran, M. F., Crowson, C. S., Pond, G. R., O'Fallon, W. M., & Gabriel, S. E. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10529 · Cited by 560
Use of the UK General Practice Research Database for pharmacoepidemiology
García Rodríguez, L. A., & Pérez Gutthann, S. (1998) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1998.00701.x · Cited by 558
Wolfe, F., Caplan, L., & Michaud, K. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21568 · Cited by 480
T cell homeostasis in patients with rheumatoid arthritis
Koetz, K., Bryl, E., Spickschen, K., O'Fallon, W. M., Goronzy, J. J., & Weyand, C. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.16.9203 · Cited by 467
Survival, prognosis, and causes of death in rheumatoid arthritis
Mitchell, D. M., Spitz, P. W., Young, D. Y., Bloch, D. A., McShane, D. J., & Fries, J. F. (1986) · Arthritis & Rheumatism · doi:10.1002/art.1780290602 · Cited by 431
Varicella-Zoster Virus Infections: Biology, Natural History, Treatment, and Prevention
STRAUS, S. E., OSTROVE, J. M., INCHAUSPÉ, G., FELSER, J. M., FREIFELD, A., CROEN, K. D., & SAWYER, M. H. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-2-221 · Cited by 397
The Epidemiology of Varicella and Its Complications
Choo, P. W., Donahue, J. G., Manson, J. E., & Platt, R. (1995) · Journal of Infectious Diseases · doi:10.1093/infdis/172.3.706 · Cited by 365
Yoshikawa, T. T., & Schmader, K. (2001) · Clinical Infectious Diseases · doi:10.1086/320169 · Cited by 335
Symmons, D. P. M., Jones, M., Scott, D. L., & Prior, P. (1998) · PubMed · Cited by 319
Arellano, F. M., Wentworth, C. E., Arana, A., Fernández, C., & Paul, C. F. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700622 · Cited by 274
Herpes Zoster-Varicella Infections in Immunosuppressed Patients
DOLIN, R., REICHMAN, R. C., MAZUR, M. H., & WHITLEY, R. J. (1978) · Annals of Internal Medicine · doi:10.7326/0003-4819-89-3-375 · Cited by 273
Jick, H., Terris, B. Z., Derby, L. E., & Jick, S. S. (1992) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2630010607 · Cited by 265
Use of Thiazolidinediones and Risk of Heart Failure in People With Type 2 Diabetes
Delea, T. E., Edelsberg, J. S., Hagiwara, M., Oster, G., & Phillips, L. S. (2003) · Diabetes Care · doi:10.2337/diacare.26.11.2983 · Cited by 216
Wolfe, F., Michaud, K. D., & Chakravarty, E. F. (2006) · Lara D. Veeken · doi:10.1093/rheumatology/kel328 · Cited by 153
van der Veen, M. J., van der Heide, A., Kruize, A. A., & Bijlsma, J. W. J. (1994) · Annals of the Rheumatic Diseases · doi:10.1136/ard.53.4.224 · Cited by 131
Herpes zoster in patients with rheumatoid arthritis treated with weekly, low-dose methotrexate
Antonelli, M. A. S., Moreland, L. W., & Brick, J. E. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)80008-a · Cited by 99
Novel Approaches to Pharmacoepidemiology Study Design and Statistical Analysis
Suissa, S. (2000) · Pharmacoepidemiology · doi:10.1002/0470842555.ch44 · Cited by 97
Self-citationSuissa, S., Ernst, P., Hudson, M., Bitton, A., & Kezouh, A. (2004) · The American Journal of Medicine · doi:10.1016/j.amjmed.2004.02.032 · Cited by 73
Self-citationJick, S. S., Kaye, J. A., Russmann, S., & Jick, H. (2006) · Contraception · doi:10.1016/j.contraception.2006.02.002 · Cited by 69
Dobloug, J. H., Førre, Ø. T., Kvien, T. K., et al. (1982) · Annals of the Rheumatic Diseases · doi:10.1136/ard.41.5.490 · Cited by 60
Fox, R. I., Fong, S., Tsoukas, C. D., et al. (1984) · The Journal of Immunology · doi:10.4049/jimmunol.132.6.2883 · Cited by 32
Cited by
Gabriel, S. E., & Michaud, K. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2669 · Cited by 891
van Assen, S., Agmon-Levin, N., Elkayam, O., Cervera, R., Doran, M. F., Dougados, M., Emery, P., Geborek, P., Ioannidis, J. P. A., Jayne, D. R. W., et al. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.137216 · Cited by 630
The emerging safety profile of JAK inhibitors in rheumatic disease
Winthrop, K. L. (2017) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2017.23 · Cited by 590
Risk of Herpes Zoster in Patients With Rheumatoid Arthritis Treated With Anti–TNF-α Agents
Strangfeld, A. (2009) · JAMA · doi:10.1001/jama.2009.146 · Cited by 542
British Association of Dermatologists’ guidelines for biologic interventions for psoriasis 2009
Smith, C. H., Anstey, A. V., Barker, J. N. W. N., Burden, A. D., Chalmers, R. J. G., Chandler, D. A., Finlay, A. Y., Griffiths, C. E. M., Jackson, K., McHugh, N. J., et al. (2009) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2009.09505.x · Cited by 464
Metadata
- Authors
- Smitten, A. L., Choi, H. K., Hochberg, M. C., Suissa, S., Simon, T. A., Testa, M. A., & Chan, K. A.
- Venue
- Arthritis Care & Research
- Publisher
- Wiley
- Published
- 2007-11-29
- Volume
- 57
- Issue
- 8
- Pages
- 1431-1438
- ISSN
- 0893-7524 (ISSN-L)
- 1529-0123
- OpenAlex
- W1991831820
- Cited by
- 281
- References
- 33
- FWCI
- 7.96
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.